The Interventional Oncology Center

Filter Your Results




Surefire Medical's Infusion Technology Studied for Treatment of Primary Liver Cancer

March 8, 2017 -- Surefire Medical, Inc. announced that clinical data from a retrospective case-controlled comparison showed that the use of Surefire infusion technology achiev…

Medtronic’s OsteoCool System Granted Expanded Indication by FDA for the Palliative Treatment of Metastatic Bone Tumors

February 15, 2017 -- Medtronic announced that the US Food and Drug Administration has approved an expanded indication for its OsteoCool RF Ablation System for the palliat…

Minimally Invasive Interventions for Nontraumatic Splenic Disorders

Aram Lee, MD; Jonathan Kessler, MD; Jinha M. Park, MD; Nasrin Fatemi, MD; and John J. Park, MD, PhD

February 2017—A review of nontraumatic clinical applications for splenic arterial interventions and the technical and anatomic considerations unique to these therapeutic options.

The Role of Interventional Oncology in Multidisciplinary Tumor Boards

David M. Liu, MD, FRCP(C), FSIR

January 2017—An analysis of the interventional oncologist’s impact on cancer patient care as part of a multidisciplinary tumor board.

NCCN Guidelines Recommend SIR-Spheres Y-90 Resin Microspheres to Treat Metastatic Colorectal Cancer

December 12, 2016 -- Sirtex Medical Limited announced that the company's SIR-Spheres yttrium-90 (Y-90) resin microspheres have been included as a category 2A recommended t…

Surefire Medical Receives Grant for Clinical Trial Investigating CAR-T Therapy Delivery Using Precision Infusion System

November 15, 2016 -- Surefire Medical, Inc. has announced that it has received a grant from the Colorado Office of Economic Development and International Trade to commence&nbs…

BTG and Mirada Medical’s Simplicit90Y Dosimetry Software Approved in Europe

October 14, 2016 -- BTG plc and Mirada Medical Ltd. announced European CE Mark certification for Simplicit90Y yttrium-90 (Y-90) dosimetry software. The software is designed to…

Meta-Analysis of Trials Comparing Radioembolization and Chemoembolization for Unresectable HCC Published

October 13, 2016 -- Findings from a systematic review and meta-analysis comparing clinical outcomes of transarterial radioembolization (TARE) versus transarterial chemoemboliz…



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.